CRISPR Therapeutics
CRSP
#3586
Rank
S$5.02 B
Marketcap
S$51.78
Share price
-0.54%
Change (1 day)
-28.15%
Change (1 year)

Market capitalization of CRISPR Therapeutics (CRSP)

Market cap: S$5.02 Billion

As of November 2026 CRISPR Therapeutics has a market cap of S$5.02 Billion. This makes CRISPR Therapeutics the world's 3586th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CRISPR Therapeutics from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026S$5.02 B-25.47%
2025S$6.73 B45.15%
2024S$4.64 B-29.3%
2023S$6.56 B53.92%
2022S$4.26 B-45.58%
2021S$7.84 B-45.64%
2020S$14.42 B188.99%
2019S$4.99 B146.61%
2018S$2.02 B60.1%
2017S$1.26 B8.3%
2016S$1.16 B

End of Day market cap according to different sources

On Nov 17th, 2026 the market cap of CRISPR Therapeutics was reported to be:

S$5.02 Billion
by Nasdaq info icon info icon
S$5.02 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
S$1.06 B-78.71%๐Ÿ‡บ๐Ÿ‡ธ USA